Sanofi will acquire the exclusive rights of Jixing Pharmaceutical to develop and commercialize Aficamten in Greater China
白云追月素
发表于 2024-12-20 14:17:28
225
0
0
Securities Times E-Company News: Sanofi and Jixing Pharmaceutical announced today the signing of a formal agreement, which stipulates that Sanofi will acquire Jixing Pharmaceutical's exclusive rights to develop and commercialize Aficamten in Greater China. The transaction is expected to be completed within 2024, and the transaction amount is not publicly disclosed.
LogoMoney.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表LogoMoney.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表LogoMoney.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Qualcomm's interest in acquiring Intel reportedly cooled down or considering equity deal
- Porsche's acquisition of Valta equity has been unconditionally approved by the State Administration for Market Regulation
- Alibaba plans to sell 100% equity of Intime to Yagor Group and others for 7.4 billion yuan, with an expected loss of approximately 9.3 billion yuan
- Alibaba sells equity in Intime for 7.4 billion yuan
- Alibaba loses 9.3 billion yuan, sells 100% equity of Intime, Youngor invests in another city
- Sanofi and Jixing reach agreement on Aficamten in Greater China market
- Sanofi and Jixing announce agreement on Aficamten in Greater China market
- Beike: Terminate the acquisition of all remaining equity of Space Intelligence, a home decoration service provider
- Beike: Terminate the acquisition of all remaining equity in Space Intelligence
- Beike terminates acquisition of all remaining equity of Love Space's parent company
-
美股市场:纽约股市三大股指4月30日涨跌不一。截至当天收盘,道琼斯工业平均指数比前一交易日上涨141.74点,收于40669.36点,涨幅为0.35%;标准普尔500种股票指数上涨8.23点,收于5569.06点,涨幅为0.15%;纳斯 ...
- joey791216
- 3 小时前
- 支持
- 反对
- 回复
- 收藏
-
美国总统特朗普近日在接受媒体采访时表示,他第二个任期不仅治理美国,也治理全世界。 特朗普于4月24日接受了《大西洋》(The Atlantic)月刊采访,这段专访于4月28日发布。 “第一次当总统时,我要做两 ...
- lfancn
- 昨天 12:10
- 支持
- 反对
- 回复
- 收藏
-
东风有限回应武汉工厂关停事宜 据第一财经,4月29日,东风汽车有限公司证实,该公司武汉工厂目前正常运行,后续也不会关停。东风有限称,该公司将在东风与日产母公司的支持下平稳有序发展,持续加速向新能源 ...
- king19831101
- 昨天 09:56
- 支持
- 反对
- 回复
- 收藏
-
4月29日凌晨,阿里巴巴开源新一代通义千问模型Qwen3(千问3),参数量为DeepSeek-R1的三分之一,成本大幅下降。据称,该模型性能全面超越R1、OpenAI-o1等领先模型,登顶全球最强开源模型。 千问3是国内首个“ ...
- 风雨中行走
- 前天 10:32
- 支持
- 反对
- 回复
- 收藏